• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma.微小RNA机制的组成部分——Dicer在前列腺腺癌中的上调。
Am J Pathol. 2006 Nov;169(5):1812-20. doi: 10.2353/ajpath.2006.060480.
2
Overexpression of Dicer in precursor lesions of lung adenocarcinoma.Dicer在肺腺癌前体病变中的过表达。
Cancer Res. 2007 Mar 1;67(5):2345-50. doi: 10.1158/0008-5472.CAN-06-3533.
3
Stimuli-dependent cleavage of Dicer during apoptosis.凋亡过程中Dicer的刺激依赖性切割。
Biochem J. 2008 Jun 15;412(3):527-34. doi: 10.1042/BJ20071461.
4
Down-regulation of dicer expression in ovarian cancer tissues.卵巢癌组织中 dicer 表达下调。
Clin Biochem. 2010 Feb;43(3):324-7. doi: 10.1016/j.clinbiochem.2009.09.014. Epub 2009 Sep 25.
5
Expression and role of Foxa proteins in prostate cancer.Foxa蛋白在前列腺癌中的表达及作用
Prostate. 2006 Jul 1;66(10):1013-28. doi: 10.1002/pros.20299.
6
Heat shock protein expression independently predicts clinical outcome in prostate cancer.热休克蛋白表达可独立预测前列腺癌的临床结局。
Cancer Res. 2000 Dec 15;60(24):7099-105.
7
Overexpression of Dicer predicts poor survival in colorectal cancer.Dicer 过表达预示结直肠癌患者预后不良。
Eur J Cancer. 2011 Jun;47(9):1414-9. doi: 10.1016/j.ejca.2011.01.006. Epub 2011 Feb 21.
8
The significance of LMO2 expression in the progression of prostate cancer.LMO2表达在前列腺癌进展中的意义。
J Pathol. 2007 Feb;211(3):278-85. doi: 10.1002/path.2109.
9
Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.在透明细胞肾细胞癌中,Dicer表达下调,并且在体外实验中,敲低Dicer可增强恶性表型转化。
Urol Oncol. 2014 Jan;32(1):46.e9-17. doi: 10.1016/j.urolonc.2013.06.011. Epub 2013 Oct 4.
10
Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma.雌激素受体β(ERβ)在人前列腺组织、癌前病变以及原发性、转移性和复发性前列腺腺癌中的差异表达。
Prostate. 2003 Feb 1;54(2):79-87. doi: 10.1002/pros.10171.

引用本文的文献

1
Phytochemical synergies in BK002: advanced molecular docking insights for targeted prostate cancer therapy.BK002中的植物化学协同作用:靶向前列腺癌治疗的先进分子对接见解
Front Pharmacol. 2025 Feb 17;16:1504618. doi: 10.3389/fphar.2025.1504618. eCollection 2025.
2
Analysis of exportins expression unveils their prognostic significance in colon adenocarcinoma: insights from public databases.输出蛋白表达分析揭示其在结肠腺癌中的预后意义:来自公共数据库的见解
Discov Oncol. 2025 Jan 8;16(1):21. doi: 10.1007/s12672-025-01748-4.
3
MicroRNA in prostate cancer: from biogenesis to applicative potential.微小 RNA 在前列腺癌中的作用:从生物发生到应用潜力。
BMC Urol. 2024 Nov 6;24(1):244. doi: 10.1186/s12894-024-01634-1.
4
The microRNA Let-7 and its exosomal form: Epigenetic regulators of gynecological cancers.微小 RNA Let-7 及其外泌体形式:妇科癌症的表观遗传调节剂。
Cell Biol Toxicol. 2024 Jun 5;40(1):42. doi: 10.1007/s10565-024-09884-3.
5
Single-molecule methylation profiles of cell-free DNA in cancer with nanopore sequencing.基于纳米孔测序的游离 DNA 单分子甲基化谱在癌症中的研究。
Genome Med. 2023 May 3;15(1):33. doi: 10.1186/s13073-023-01178-3.
6
Mechanisms Controlling MicroRNA Expression in Tumor.肿瘤中 miRNA 表达调控的机制
Cells. 2022 Sep 13;11(18):2852. doi: 10.3390/cells11182852.
7
ADAR1-Mediated RNA Editing and Its Role in Cancer.ADAR1介导的RNA编辑及其在癌症中的作用。
Front Cell Dev Biol. 2022 Jul 11;10:956649. doi: 10.3389/fcell.2022.956649. eCollection 2022.
8
Polymorphism rs3742330 in microRNA Biogenesis Gene Is Associated with Pseudoexfoliation Glaucoma in Saudi Cohort.微小RNA生物发生基因中的多态性rs3742330与沙特人群中的假性剥脱性青光眼相关。
Genes (Basel). 2022 Mar 10;13(3):489. doi: 10.3390/genes13030489.
9
Methylation of and as a Biomarker for the Detection of Lung Cancer.作为肺癌检测生物标志物的[具体甲基化对象]甲基化
Cancers (Basel). 2021 Dec 6;13(23):6139. doi: 10.3390/cancers13236139.
10
Integrated Analysis of Mutations, miRNA and mRNA Expression in Glioblastoma.胶质母细胞瘤中突变、miRNA与mRNA表达的综合分析
Int J Gen Med. 2021 Nov 16;14:8281-8292. doi: 10.2147/IJGM.S336421. eCollection 2021.

本文引用的文献

1
Partners in dicing.切割伙伴。
Genome Biol. 2006;7(3):210. doi: 10.1186/gb-2006-7-3-210. Epub 2006 Mar 31.
2
MicroRNAs in cell proliferation, cell death, and tumorigenesis.细胞增殖、细胞死亡和肿瘤发生中的微小RNA
Br J Cancer. 2006 Mar 27;94(6):776-80. doi: 10.1038/sj.bjc.6603023.
3
A microRNA expression signature of human solid tumors defines cancer gene targets.人类实体瘤的微小RNA表达特征可确定癌症基因靶点。
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61. doi: 10.1073/pnas.0510565103. Epub 2006 Feb 3.
4
Silencing of survivin gene by small interfering RNAs produces supra-additive growth suppression in combination with 17-allylamino-17-demethoxygeldanamycin in human prostate cancer cells.小干扰RNA介导的生存素基因沉默与17-烯丙基氨基-17-去甲氧基格尔德霉素联合应用对人前列腺癌细胞产生超加成性生长抑制作用。
Mol Cancer Ther. 2006 Jan;5(1):179-86. doi: 10.1158/1535-7163.MCT-05-0132.
5
The role of PACT in the RNA silencing pathway.PACT在RNA沉默途径中的作用。
EMBO J. 2006 Feb 8;25(3):522-32. doi: 10.1038/sj.emboj.7600942. Epub 2006 Jan 19.
6
MicroRNAs as oncogenes.作为致癌基因的微小RNA
Curr Opin Genet Dev. 2006 Feb;16(1):4-9. doi: 10.1016/j.gde.2005.12.005. Epub 2005 Dec 19.
7
A human, ATP-independent, RISC assembly machine fueled by pre-miRNA.一种由前体微小RNA驱动的、不依赖ATP的人类RNA诱导沉默复合体组装机器。
Genes Dev. 2005 Dec 15;19(24):2979-90. doi: 10.1101/gad.1384005.
8
Stem/progenitor and intermediate cell types and the origin of human prostate cancer.干细胞/祖细胞及中间细胞类型与人类前列腺癌的起源
Differentiation. 2005 Dec;73(9-10):463-73. doi: 10.1111/j.1432-0436.2005.00047.x.
9
Identification of novel argonaute-associated proteins.新型AGO相关蛋白的鉴定。
Curr Biol. 2005 Dec 6;15(23):2149-55. doi: 10.1016/j.cub.2005.10.048. Epub 2005 Nov 10.
10
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression.前列腺癌的综合基因组和蛋白质组分析揭示了转移进展的特征。
Cancer Cell. 2005 Nov;8(5):393-406. doi: 10.1016/j.ccr.2005.10.001.

微小RNA机制的组成部分——Dicer在前列腺腺癌中的上调。

Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma.

作者信息

Chiosea Simion, Jelezcova Elena, Chandran Uma, Acquafondata Marie, McHale Teresa, Sobol Robert W, Dhir Rajiv

机构信息

Department of Pathology, University of Pittsburgh, University of Pittsburgh Medical Center Presbyterian, C920.1, 200 Lothrop St., Pittsburgh, PA 15213, USA.

出版信息

Am J Pathol. 2006 Nov;169(5):1812-20. doi: 10.2353/ajpath.2006.060480.

DOI:10.2353/ajpath.2006.060480
PMID:17071602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1780192/
Abstract

MicroRNAs are small noncoding 18- to 24-nt RNAs that are predicted to regulate expression of as many as 30% of protein-encoding genes. In prostate adenocarcinoma, 39 microRNAs are up-regulated, and six microRNAs are down-regulated. Production and function of microRNA requires coordinated processing by proteins of the microRNA machinery. Dicer, an RNase III endonuclease, is an essential component of the microRNA machinery. From a gene array analysis of 16 normal prostate tissue samples, 64 organ-confined, and four metastatic prostate adenocarcinomas, we identified an up-regulation of major components of the microRNA machinery, including Dicer, in metastatic prostate adenocarcinoma. Immunohistochemical studies on a tissue microarray consisting of 232 prostate specimens confirmed up-regulation of Dicer in prostatic intraepithelial neoplasia and in 81% of prostate adenocarcinoma. The increased Dicer level in prostate adenocarcinoma correlated with clinical stage, lymph node status, and Gleason score. Western blot analysis of benign and neoplastic prostate cell lines further confirmed Dicer up-regulation in prostate adenocarcinoma. Dicer up-regulation may explain an almost global increase of microRNA expression in prostate adenocarcinoma. The presence of up-regulated microRNA machinery may predict the susceptibility of prostate adenocarcinoma to RNA interference-based therapy.

摘要

微小RNA是一类长度为18至24个核苷酸的小型非编码RNA,据预测可调控多达30%的蛋白质编码基因的表达。在前列腺腺癌中,有39种微小RNA上调,6种微小RNA下调。微小RNA的产生和功能需要微小RNA机制中的蛋白质协同加工。Dicer是一种核糖核酸酶III内切核酸酶,是微小RNA机制的重要组成部分。通过对16个正常前列腺组织样本、64个器官局限性前列腺腺癌样本和4个转移性前列腺腺癌样本进行基因芯片分析,我们发现在转移性前列腺腺癌中,微小RNA机制的主要成分(包括Dicer)上调。对由232个前列腺标本组成的组织芯片进行免疫组织化学研究证实,在前列腺上皮内瘤变和81%的前列腺腺癌中Dicer上调。前列腺腺癌中Dicer水平的升高与临床分期、淋巴结状态和 Gleason评分相关。对良性和肿瘤性前列腺细胞系进行蛋白质印迹分析进一步证实前列腺腺癌中Dicer上调。Dicer上调可能解释了前列腺腺癌中微小RNA表达几乎整体增加的现象。上调的微小RNA机制的存在可能预示前列腺腺癌对基于RNA干扰的治疗的敏感性。